Martin Health System Unveils Xenex Germ-Zapping Robot™ more

Jesuit High School Alumnus Donates Xenex Germ-Zapping Robot to His Alma Mater more

BiO2 Medical Announces Successful Completion of the Angel® Catheter Pivotal Clinical Trial more

Xenex Awarded Premier, Inc. Group Purchasing Contract to Offer Germ-Zapping Robot™ Room Disinfection Technology to Premier Member Hospitals more

SA bioscience companies strike new deal to expand scope of stem cell research more

TFS Corporation share price flat despite soaring earnings more

TFS Corporation doubles quarterly profit more

Innovation makes money grow on trees more

Xenex Germ-Zapping Robot™ Destroys Ebola Virus & Anthrax Spores in New Study Performed at Texas Biomed Biosafety Level 4 Lab more

Indian sandalwood oil producer ramps up production to supply new markets more

Cytocentrics Inc. wins Innovator Award at recent event more

Key Opinion Leader (KOL) Calls for New Standard to Close Port-Site Hernias in Lap and Robotic Surgeries more

Surgical Site Infections Decrease 100% after Trinity Medical Center Implements Infection Control Bundle more

Court Order Requires Tru-D to Cease False and Misleading Statements more

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration more

San Antonio biotech firm CEO is heading west more

Sandalwood grower smells a fortune more

Explore the UV LED market that is expected to reach USD 369.58 million by 2020 more

Ten Life Sciences Companies to Watch in Central Texas more

San Antonio’s Xenex signs national contract with HealthTrust more

Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio more

Benzac® Intensive Spot Treatment Named Best Acne Treatment of 2015 by HEALTH Magazine more

neoSurgical® Reports Commercial Milestone of 2000 US Procedures more

Launch of latest hyaluronic acid based filler range more

Galderma Laboratories Announces the Nationwide Availability of Benzac® more

BioMed SA Celebrates 10th Anniversary more

TFS completes US pharma acquisition more

Finally, Good News for Anyone Looking for a Gentle Acne Treatment more

4th Peer-Reviewed Study to Credit Xenex Germ-Zapping Robots for Infection Rate Decrease more

A pair of biotech VCs take aim at raising SA’s status more

BiO2 Medical raises $4M for device that prevents embolism more

How SA landed Cytocentrics more

Sandalwood firm sticks to forecasts more

Two New Studies Show Decrease in Hospital Acquired Infections after Xenex Germ-Zapping Robots Used for Room Disinfection more

Xenex Offers Industry’s First HAI Reduction Guarantee; Multiple Hospitals Report Decrease in Infection Rates When Using Xenex Germ-Zapping Robots for Room Disinfection

Global concern about antibiotic resistance and the spread of deadly viruses like MERS and Ebola is at an all-time high. Meanwhile, a recent Centers for Disease Control & Prevention (CDC) progress report found that U.S. hospitals have not met national healthcare associated infection (HAI) reduction goals. As evidence of the Xenex Germ-Zapping Robot™’s ability to help hospitals destroy the pathogens that cause HAIs continues to mount, Xenex Disinfection Services today announced its HAI Reduction Guarantee, a new program designed to quickly integrate Xenex robots into healthcare facilities.

Hospitals that purchased Xenex Pulsed Xenon Full Spectrum™ ultraviolet (UV) room disinfection robots have reported and published greater than 50 percent decreases in methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C.diff) infection rates in peer-reviewed literature, documenting how they used the Xenex robot to reduce infection rates by quickly destroying the microorganisms that cause hospital acquired infections. The robot pulses intense UV light covering the entire UV spectrum, destroying viruses, bacteria and bacterial spores including C.diff in a five-minute disinfection cycle. Designed for speed, effectiveness and ease of use, hospital cleaning staff efficiently integrate Xenex robots into a hospital’s existing operations and HAI reduction strategy.

After carefully evaluating infection prevention protocols from Xenex hospital customers that experienced HAI rate reductions, Xenex created the industry’s first HAI Reduction Guarantee, which provides up to a full refund if in the first 12 months of use, customers do not achieve an infection rate reduction sufficient to produce savings to cover the annualized cost of acquiring and operating the Xenex robots. The guarantee applies to HAIs including those which hospitals are required to report to the Centers for Medicare and Medicaid Services (CMS) as key performance standards in the Value Based Purchasing (VBP) and Hospital Acquired Condition (HAC) Reduction programs such as C.diff, MRSA and Surgical Site Infections (SSIs).

“Multiple hospitals using Xenex robots have experienced HAI rate reductions after the hospital began using Xenex for room disinfection. Three hospitals have published their HAI rate reductions in peer-reviewed journals and five more HAI reduction studies are in press or in review,” said Morris Miller, CEO of Xenex. “We developed the HAI Reduction Guarantee for other hospitals and health systems that are looking for a proven solution to reduce their infection rates. Our team of experienced infection preventionists, epidemiologists and account managers work closely with hospital staff to rapidly integrate the robots into the hospital's operations to ensure their proper use and deployment, which will result in a reduction in HAI rates.”

Eliminate Toxic Mercury in Hospitals

In addition to its HAI Reduction Guarantee, Xenex has initiated a Mercury Elimination Program™, which allows hospitals in the U.S. and Canada to exchange portable mercury bulb UV disinfection devices in their facilities for Xenex robots so they can help reduce hospital acquired infection rates and minimize the presence of toxic mercury in their facilities.

“We have been told by hospitals using mercury bulb UV devices how bad they smell, that the devices discolor the facility floors, and they take too long to disinfect a room. Many hospitals acquired mercury UV disinfection technology because they didn’t understand the difference between full-spectrum pulsed xenon UV and single spectrum mercury UV light. Now they do,” continued Miller. “We support hospitals’ elimination of toxic mercury in their facilities and we believe so strongly in our technology that we are willing to invest in our customers’ success. The goal of this campaign is simple. We want to get our robots into hospitals quickly so fewer patients will suffer from HAIs. Xenex offers the only UV disinfection technology that utilizes pulsed xenon to create germicidal UVC light and is the only UV disinfection technology shown, in peer-reviewed published studies, to be effective in reducing HAI rates.”

Xenex is now offering a significant discount on the purchase of Xenex germ-zapping robots when hospitals trade in their mercury UV devices. The offer, which is good from July 1, 2015 to September 30, 2015, is open to all hospitals, including those facilities that are contracted with Xenex through Group Purchasing Organization (GPO) agreements.

Xenex will work closely with participating healthcare facilities on the return or proper disposal of their mercury UV devices. When a mercury lamp is to be disposed, it is subject to the current EPA Toxicity Characteristic Leaching Procedure (TCLP) disposal criteria. This test is used to determine if an item can be managed as hazardous or non-hazardous waste. Some mercury lamps are not TCLP compliant and should be managed as a hazardous waste under the EPA Universal Waste Rules for fluorescent lamps. All disposal options will be evaluated with respect to federal, state, and local requirements, and Xenex will strive to recycle products through qualified recycling facilities.

Only UV Disinfection System Proven to Reduce HAIs

MD Anderson Cancer Center, the Central Texas Veterans Health Care System, Cooley Dickinson Health Care (an affiliate of Massachusetts General Hospital and Partners HealthCare System) and other hospitals have published 11 studies providing evidence of the Xenex robot’s efficacy in highly regarded scientific journals that include the American Journal of Infection Control (AJIC), Journal of Infection Prevention, Infection Control & Hospital Epidemiology (ICHE) and BMC Infectious Diseases. Hospitals that purchased Xenex robots have reported greater than 50 percent decreases in MRSA and C.diff infection rates in peer-reviewed literature, documenting how they used the Xenex robot in their real-world hospital environment to reduce infection rates.

Source: http://www.businesswire.com/news/home/20150626005700/en/Xenex-Offers-Industry%E2%80%99s-HAI-Reduction-Guarantee-Multiple#.VcDpHLV8rCo

June 26th 2015 back

Xenex to expand sales of ‘germ-zapping robots’ to more European nations more

West Australian Indian sandalwood oil producer purchases American drug companies more

Sandlewood grower to buy US-based pharmaceutical firms more

Cytocentrics has big plans for San Antonio more

TFS Corporation Limited jumps on acquisitions: What you need to know more

Australian firm acquires multiple San Antonio bioscience companies; Deal could be worth $270 million more

TFS To Acquire ViroXis And Santalis Pharma - Quick Facts more

DNAtrix Collaborators Present Data on a Novel Oncolytic Adenovirus Expressing OX40 Ligand that Promotes Antitumor Immunity more

San Antonio expected to become bigger global research player as result of Cytocentrics deal more

Cytocentrics Wins $1 Million Incentive and Warm Welcome to San Antonio more

San Antonio approves major incentive deal to lure German biotech firm more

German Biosciences Company Relocating Headquarters to San Antonio more

Cytocentrics looking to relocate HQ to San Antonio, create 300 jobs more

Cytocentrics CEO: Biotech company passed up bigger financial offers to move to San Antonio more

Milwaukee VA center cleared to use germ-zapping robots more

GAO Affirms VA Contract for Mercury-Free UV Disinfection System, Milwaukee VA Hospital Orders Xenex Full-Spectrum™ Germ-Zapping Robots™ more

Pivotal Investigation of BiO2 Medical's Angel Catheter Exceeds Enrollment Expectations more

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer more

Here’s why these 4 companies are soaring higher today more

Harvard gets wood more

2 Works for You helps teen diagnosed with brain cancer denied access to experimental treatment more

Harvard University sees the good oil in NT sandalwood plantation more

San Antonio bioscience companies to team up on critical research more

Germ-zapping R2-D2 look-alike works at Renown more

Are TFS Corporation Limited shares an absolute bargain? more

Med tech start-up exits Bank of Ireland Seed Fund with US$21m valuation more

Galway-based NeoSurgical exits Kernel Capital more

Xenex sells Germ-Zapping robot to Iowa nonprofit hospital more

Broadlawns Employs Xenex Robot to Eradicate Germs more

Benzac® Acne Solutions Premieres Its First-Ever “Insta-Dramedy” Webseries more

Sandalwood grower enlists F1 star more

StemBioSys closes $8m in funding to help launch its stem cell culture system more

Irish start-up neoSurgical has just signed an exclusive distribution deal for the US market. But, as founder and CEO Barry Russell explains, it has taken persistence and courage to get the company this far more

Xenex exporting hospital-cleaning robots to Europe more

Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection more

Takes $8M to Build Homes For Stem Cells more

San Antonio biomedical company StemBioSys scores major funding more

Lexington Fire Department chosen to conduct trial on new EMS Equipment more

Xenex Rebuts Clorox Attack Following NAD Press Release more

San Antonio’s Xenex files lawsuit against Cloroxn more

Lexington Fire Dept. Among First In Kentucky Testing New Device more

Here’s why today is a good day to buy TFS Corporation Limited shares more

Over-the-counter (OTC) remedies rescue consumers from skin and health issues that are—at the time—more pressing than fine lines and wrinkles more

Germ-zapping Dalek-like robots trialed at King’s Lynn’s Queen Elizabeth Hospital to reduce the spread of infection more

Seven Women Run Tech Startups in San Antonio to Watch more

UV light from robots disinfects hospital rooms more

TFS rises on upgraded guidance more

Biological assets boost valuation for TFS more

NPSF Patient Safety Coalition Welcomes Xenex more

UV Disinfection Equipment Market is Expected to Reach $2.8 Billion by 2020 – Allied Market Research more

Scent of success more

BiO2 Medical Begins Enrollment for the Pivotal Investigation of the Angel® Catheter more

Baptist Health's new germ-zapping robots use untraviolet light as a disinfectant more

Baptist Health adds "cleaning robots" more

The Only Full Spectrum™ Pulsed Xenon UV Disinfection System more

Benzac® Acne Solutions Launches in the US more

State of health care: Xenex CEO says company is winning war against deadly infections more

The Health Cell to present event focusing on San Antonio’s health care and biosciences sector more

San Antonio developing biotech executive talent more

Xenex’s latest funding exceeds expectations, expands international opportunities more

San Antonio bioscience company Xenex secures major funding more

Germ-Zapping Robot Makes House Call for Texas Baby more

Hospitals name their disinfecting robots to add personality more

The robot will clean up now: More hospitals buying automated systems to reduce infections more

New Study Shows Pulsed Xenon UV Light Effective in Reducing C. diff, MRSA and VRE in the Hospital Environment more

Forecast: Three San Antonio biomedical companies to watch in 2015 more

Here’s why these 4 stocks are soaring higher today more

Sandalwood the good oil for US funds more

Oil Investment Could Put A Smile On The Faces Of Harvard Students more

Harvard takes stake in TFS more

Aromatherapy at home can be easy more

TFS up on US acne product launch more

BiO2 Medical Receives IDE Approval to Initiate Pivotal Investigation of the Angel® Catheter more

StemBioSys Inc. to Present at Biotech Showcase™ 2015 more

Galderma Laboratories Launches Its First Over-the-Counter Acne Regimen, Benzac® Acne Solutions more